XYLO Medigus: חוב להון עצמי

The Xylo Technologies Ltd. (XYLO) price chart on the GURU.Markets platform demonstrates a total debt-to-equity ratio of 0.43. This investment holding (formerly Medigus) is currently monetizing its technological developments. Business growth relies on the acquisition of promising fintech projects and B2B services to capture the online market. The structural stability is based on medtech management and the support of innovative digital startups.

This ratio determines the degree of financial leverage by comparing total liabilities to equity to assess the stability of the capital structure. By analyzing the change in the total debt-to-equity ratio, an investor determines the balance between bankruptcy risks and expansion rates, which is critical for Xylo Technologies Ltd. (XYLO) in maintaining its Israeli laboratories and US server capacities.